These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

72 related items for PubMed ID: 8259549

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Distribution of the recombinant coagulation factor 125I-rFVIIa in rats.
    Beeby TL, Chasseaud LF, Taylor T, Thomsen MK.
    Thromb Haemost; 1993 Sep 01; 70(3):465-8. PubMed ID: 8259550
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Internalization and degradation of recombinant human coagulation factor VIIa by the human hepatoma cell line HuH7.
    Chang GT, Kisiel W.
    Thromb Haemost; 1995 Feb 01; 73(2):231-8. PubMed ID: 7792735
    [Abstract] [Full Text] [Related]

  • 5. Increased volume of distribution for recombinant activated factor VII and longer plasma-derived factor VII half-life may explain their long lasting prophylactic effect.
    Mathijssen NC, Masereeuw R, Holme PA, van Kraaij MG, Laros-van Gorkom BA, Peyvandi F, van Heerde WL.
    Thromb Res; 2013 Aug 01; 132(2):256-62. PubMed ID: 23834817
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Feasibility of using recombinant factor VIIa in continuous infusion.
    Schulman S, Bech Jensen M, Varon D, Keller N, Gitel S, Horoszowski H, Heim M, Martinowitz U.
    Thromb Haemost; 1996 Mar 01; 75(3):432-6. PubMed ID: 8701403
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Recombinant activated factor VIIa in uncontrolled bleeding: a haemostasis laboratory study in non-haemophilia patients.
    Brandsborg S, Sørensen B, Poulsen LH, Ingerslev J.
    Blood Coagul Fibrinolysis; 2006 Jun 01; 17(4):241-9. PubMed ID: 16651865
    [Abstract] [Full Text] [Related]

  • 11. Monitoring rFVIIa 90 μg kg⁻¹ dosing in haemophiliacs: comparing laboratory response using various whole blood assays over 6 h.
    Brophy DF, Martin EJ, Christian Barrett J, Nolte ME, Kuhn JG, Gerk PM, Carr ME, Pelzer H, Agersø H, Ezban M, Hedner U.
    Haemophilia; 2011 Sep 01; 17(5):e949-57. PubMed ID: 21362113
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Pharmacokinetics of human activated protein C. 1st communication: plasma concentration and excretion of a lyophilized purified human activated protein C after intravenous administration in the mouse and the rabbit.
    Ishii S, Mochizuki T, Nagao T, Sugiki S, Kudo S, Harakawa N, Taniguchi K, Igarashi Y, Kondo S, Kiyoki M.
    Arzneimittelforschung; 1995 May 01; 45(5):636-44. PubMed ID: 7612068
    [Abstract] [Full Text] [Related]

  • 14. Population pharmacokinetics of recombinant factor VIIa in volunteers anticoagulated with acenocoumarol.
    Girard P, Nony P, Erhardtsen E, Delair S, Ffrench P, Dechavanne M, Boissel JP.
    Thromb Haemost; 1998 Jul 01; 80(1):109-13. PubMed ID: 9684795
    [Abstract] [Full Text] [Related]

  • 15. Recombinant fusion protein linking factor VIIa with albumin (rVIIa-FP): Tissue distribution in rats.
    Herzog E, Harris S, McEwen A, Henson C, Pragst I, Dickneite G, Schulte S, Zollner S.
    Thromb Res; 2014 Aug 01; 134(2):495-502. PubMed ID: 24958222
    [Abstract] [Full Text] [Related]

  • 16. Pharmacokinetics of a new human monoclonal antibody against cytomegalovirus. First communication: plasma concentration, distribution, metabolism and excretion of the new monoclonal antibody, regavirumab after intravenous administration in rats and rabbits.
    Arizono H, Ishii S, Nagao T, Kudo S, Sasaki S, Kondo S, Kiyoki M.
    Arzneimittelforschung; 1994 Jul 01; 44(7):890-8. PubMed ID: 7945529
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of potential antigenicity of active-site-inhibited recombinant human FVIIa (FFR-rFVIIa) in an immune-tolerant rat model.
    Nicolaisen EM, Kristensen H, Kristensen A, Hedner U.
    Thromb Haemost; 2002 May 01; 87(5):836-9. PubMed ID: 12038786
    [Abstract] [Full Text] [Related]

  • 18. Intranasal DDAVP induced increases in plasma von Willebrand factor alter the pharmacokinetics of high-purity factor VIII concentrates in severe haemophilia A patients.
    Deitcher SR, Tuller J, Johnson JA.
    Haemophilia; 1999 Mar 01; 5(2):88-95. PubMed ID: 10215955
    [Abstract] [Full Text] [Related]

  • 19. Clearance of rFVIIa and NN1731 after intravenous administration to Beagle dogs.
    Agersø H, Kristensen NR, Østergaard H, Karpf DM, Hermit MB, Pelzer H, Petersen LC, Ezban M.
    Eur J Pharm Sci; 2011 Apr 18; 42(5):578-83. PubMed ID: 21382491
    [Abstract] [Full Text] [Related]

  • 20. Clearance of recombinant tissue factor pathway inhibitor (TFPI) in rabbits.
    Palmier MO, Hall LJ, Reisch CM, Baldwin MK, Wilson AG, Wun TC.
    Thromb Haemost; 1992 Jul 06; 68(1):33-6. PubMed ID: 1514170
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.